Search results for " Reproductive"

showing 10 items of 614 documents

[Drugs use in pregnancy in the Valencia Region and the risk of congenital anomalies].

2017

Background Despite the potential risks of drug use during pregnancy, consumption has increased in recent decades. Objective To identify the risk of congenital anomalies (CA) associated with the use of drugs in primary care in pregnant women resident in the Valencia Region. Methods A case-control study, considering a case as a less than one year old live birth in 2009–2010, diagnosed with a CA and resident in the Valencia Region, obtained from the CA population-based registry. Controls were selected from the Metabolic Disease Registry, and the drugs prescribed and dispensed from the Integral Management of Pharmaceutical Services. Crude odds ratio (OR) was calculated with its 95% confidence i…

DrugAdultMalemedicine.medical_specialtyPreparación farmacéuticaEmbarazomedia_common.quotation_subjectPopulationLogistic regressionPediatricsRJ1-570Comunitat Valenciana03 medical and health sciencesYoung Adult0302 clinical medicinePregnancyRisk FactorsManagement of Technology and InnovationInternal medicineAmbulatory CareMedicineAnomalías congénitasHumans030212 general & internal medicineeducationmedia_commonPregnancyeducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryInfant NewbornAbnormalities Drug-InducedOdds ratioDexketoprofenmedicine.diseaseConfidence intervalSurgeryPregnancy ComplicationsSpainCase-Control StudiesFemalebusinessLive birthmedicine.drugFactores de riesgoAnales de pediatria (Barcelona, Spain : 2003)
researchProduct

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.

2017

International audience; PurposeTo provide an up-to-date account of drug prescription during pregnancy in France from 2011 to 2014 using the permanent sample of the French national computerized healthcare database and with a focus on recommended supplementations, fetotoxic drugs and teratogenic drugs.MethodsAll pregnancies identified by the International Classification of Diseases, 10th Revision codes list in the hospitalization database, lasting more than 9 weeks of amenorrhea and whose delivery occurred between 01/01/2011 and 12/31/2014, were included. Drugs delivered between the trimester before and until the end of the pregnancy were included. Drug exposure prevalence was calculated for …

DrugAdultPediatricsmedicine.medical_specialtypharmacoepidemiologyPrescription drugPrescription DrugsNational Health ProgramsEpidemiologymedia_common.quotation_subject[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics030226 pharmacology & pharmacy03 medical and health sciencesYoung Adult0302 clinical medicinePregnancymedicineHumansPharmacology (medical)Medical prescriptionPregnancy Trimestersmedia_commonPregnancy030219 obstetrics & reproductive medicinebusiness.industrydrug recommendationsadministrative healthcare databasePharmacoepidemiologymedicine.diseaseDrug classTeratogensprescription medicationsAmenorrheaFemaleFrancePregnancy Trimestersmedicine.symptombusinessPharmacoepidemiology and drug safety
researchProduct

Does levonorgestrel emergency contraceptive have a post-fertilization effect? A review of its mechanism of action.

2016

Background: Recent studies have identified that levonorgestrel administered orally in emergency contraception (LNG-EC) is only efficacious when taken before ovulation. However, the drug does not consistently prevent follicular rupture or impair sperm function. Objective: The present systematic review is performed to analyze and more precisely define the extent to which pre-fertilization mechanisms of action may explain the drug's efficacy in pregnancy avoidance. We also examine the available evidence to determine if pre-ovulatory drug administration may be associated with post-fertilization effects. Conclusion: The mechanism of action of LNG-EC is reviewed. The drug has no ability to alter…

DrugPregnancymedicine.medical_specialty030219 obstetrics & reproductive medicinebusiness.industryObstetricsHealth Policymedia_common.quotation_subjectmedicine.medical_treatmentmedicine.diseaseMenstruation03 medical and health sciencesPhilosophy0302 clinical medicineFamily planningmedicineLevonorgestrelEmergency contraception030212 general & internal medicineSystematic ReviewbusinessOvulationMenstrual cyclemedicine.drugmedia_commonThe Linacre quarterly
researchProduct

Menopause and diabetes: EMAS clinical guide

2018

Abstract Introduction Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independently of ageing has been a matter of debate. Controversy also exists about the benefits and risks of menopausal hormone therapy (MHT) in women with T2DM. Aims To summarise the evidence on 1) the effect of menopause on metabolic parameters and the risk of T2DM, 2) the effect of T2DM on age at menopause, 3) the effect of MHT on the risk of T2DM, and 4) the management of postmenopausal women with T2DM. Materials and methods Literature review and consensus of experts’ opinions. Results and conclusion Metabolic changes during the menopausal transition include an increase in and the central redis…

ESTROGEN REPLACEMENTmedicine.medical_specialtyHORMONE-REPLACEMENT THERAPYendocrine system diseasesmedicine.medical_treatment030209 endocrinology & metabolismDiseaseDydrogesteroneGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicine3123 Gynaecology and paediatricsRisk FactorsInternal medicineDiabetes mellitusType 2 diabetes mellitusDiabetes MellitusmedicineHumansNATURAL MENOPAUSEMenopausal hormone therapy; Menopause; Type 2 diabetes mellitus; Estrogen Replacement Therapy; Female; Humans; Incidence; Risk Factors; Diabetes Mellitus Type 2; MenopauseESTRADIOLMETABOLIC SYNDROME030219 obstetrics & reproductive medicineProgestogenINSULIN SENSITIVITYbusiness.industryIncidenceEstrogen Replacement TherapyENERGY-EXPENDITUREnutritional and metabolic diseasesObstetrics and GynecologyType 2 Diabetes MellitusHormone replacement therapy (menopause)medicine.disease3. Good healthMenopausePOSTMENOPAUSAL WOMENDiabetes Mellitus Type 23121 General medicine internal medicine and other clinical medicineRISK-FACTORSFemaleHEALTHMenopauseMetabolic syndromebusinessType 2Menopausal hormone therapymedicine.drug
researchProduct

Inefficiency in the French System of Higher Education

1982

International audience; This article sets out to present the French higher education system as it exists at present, pinpointing the main causes of the malfunctioning or inefficiency now unanimously attributed to it by students, employers, governments and even teachers. The trends and reforms of the last 15 years or so already bear witness to a fundamental adaptation of the system to new guiding concerns. Yet this development is slow and uneven, being kept in check by certain institutions, themselves so well-established as to be taken for granted. We shall attempt here to identify them.

Economic growth030219 obstetrics & reproductive medicineHigher educationbusiness.industry[SHS.EDU]Humanities and Social Sciences/Education4. EducationEfficience[SHS.EDU] Humanities and Social Sciences/Education05 social sciences050301 educationSystème d'enseignement supérieurEnseignement supérieurEducation03 medical and health sciences0302 clinical medicineOrganizational changeDevelopment economicsEconomicsFranceComparative educationbusinessInefficiency0503 educationEuropean Journal of Education
researchProduct

Sirenomelia, case report and review of the literature.

2020

We present a case of sirenomelia diagnosed in the first trimester of pregnancy. The ultrasound examination showed fused lower extremities and an anechoic structure in the lower abdomen that is clue in the early diagnosis. The postmortem study showed the existence of a single umbilical artery (vitelline artery), with an origin in the abdominal aorta. This finding not only explained the presence of a vascular steal with subsequent underdeveloped of pelvic organs, but also differentiated this condition from caudal regression syndrome.

Ectromelia030231 tropical medicine03 medical and health sciences0302 clinical medicinePregnancymedicine.arterymedicineHumansAbnormalities MultipleUltrasonographyPregnancy030219 obstetrics & reproductive medicineCaudal regression syndromeSingle umbilical arterybusiness.industryAbdominal aortaUltrasoundObstetrics and GynecologyAnatomyArteriesmedicine.diseasePregnancy Trimester Firstmedicine.anatomical_structureSirenomeliaPediatrics Perinatology and Child HealthAbdomenFemaleVitelline arteriesbusinessThe journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
researchProduct

One for all or all for one? The evolution of embryo morphokinetics

2017

Embryo Culture Techniques0301 basic medicineAndrology03 medical and health sciences030219 obstetrics & reproductive medicine030104 developmental biology0302 clinical medicineReproductive MedicineObstetrics and GynecologyEmbryoBiologyEmbryo TransferFertility and Sterility
researchProduct

A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis

2017

Maternal smoking during pregnancy is linked to reduced birth weight but the gestation at onset of this relationship is not certain. We present a systematic review of the literature describing associations between maternal smoking during pregnancy and ultrasound measurements of fetal size, together with an accompanying meta-analysis. Studies were selected from electronic databases (OVID, EMBASE and Google Scholar) that examined associations between maternal smoking or smoke exposure and antenatal fetal ultrasound measurements. Outcome measures were first, second or third trimester fetal measurements. There were 284 abstracts identified, 16 papers were included in the review and the meta-anal…

Embryologysmoking habitsPhysiologyMaternal Healthlcsh:MedicineFetal DevelopmentHabitsDatabase and Informatics Methods0302 clinical medicineMathematical and Statistical TechniquesPregnancyMedicine and Health SciencesSmoking HabitsBirth Weight030212 general & internal medicineFemurDatabase Searchinglcsh:ScienceMusculoskeletal System2. Zero hunger030219 obstetrics & reproductive medicineMultidisciplinaryFetal Growth RetardationObstetricsSmokingObstetrics and GynecologyResearch AssessmentFetal Measurements3. Good healthPhysiological ParametersMeta-analysisPregnancy Trimester SecondPhysical SciencesGestationFemaleAnatomyStatistics (Mathematics)Research Articlemedicine.medical_specialtySystematic ReviewsBirth weightPregnancy Trimester Thirdsystematic reviewsStandard scoreResearch and Analysis Methodsregnancydatabase searching03 medical and health sciencesmedicineHumansFemurStatistical MethodsSkeletonGynecologyPregnancyFetusBehaviorFetusesbusiness.industrylcsh:RBody WeightBiology and Life Sciencesmedicine.diseasemeta-analysisPregnancy Trimester FirstWomen's Healthfetuseslcsh:QfemurTobacco Smoke PollutionbusinessHeadMathematicsMeta-AnalysisDevelopmental Biologybright weight
researchProduct

Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women.

2019

Metformin is one of the treatments used for pcoS pathology decreasing body weight, plasma androgen, FSH and glucose levels. Unfortunately, there is little known about metformin’s effects on lipid metabolism, a crucial process in pcoS pathology. We have employed a lipidomic approach to explore alterations in the plasma lipid profile of patients with PCOS following metformin treatment. The aim is to offer new insights about the effect of metformin in PCOS patients. Plasma samples were obtained from 27 subjects prior to and following 12 weeks of metformin treatment. A detailed biochemical characterization and lipidomic profile was performed. Metformin reduces BMI, HOMA-IR, fSH and androstenedi…

Endocrine reproductive disordersmedicine.medical_specialtyendocrine system diseasesmedicine.drug_classlcsh:Medicinemedicine.disease_causeArticleInternal medicinemedicineHumansAndrostenedionelcsh:ScienceSphingolipidsMultidisciplinarybusiness.industrylcsh:Rdigestive oral and skin physiologynutritional and metabolic diseasesLipid metabolismMetabolismAndrogenSphingolipidPolycystic ovaryMetforminMetforminOxidative StressEndocrinologyLipidomicslcsh:QFemalebusinessOxidation-ReductionOxidative stressmedicine.drugPolycystic Ovary SyndromeScientific reports
researchProduct

Effects of different progesterone levels on reproductive outcomes in assisted reproductive technologies: from molecular basis to treatment strategies

2023

Purpose: The aim of this narrative review is to offer an overview about the role of progesterone levels on pregnancy outcome in patients undergoing assisted reproductive technologies (ARTs). Methods: A detailed computerized search of the literature was performed in the main electronic databases (MEDLINE, EMBASE, Web of Science) to determine the importance of elevated progesterone levels at different stages of the cycle for pregnancy rates in the in vitro fertilization (IVF) cycle. Our review also provides information on the differences between elevated progesterone levels and their interpretation in normal and in poorly responding women. Results: After careful evaluation, our search strateg…

EndocrinologyProgesterone; assisted reproductive technology; human chorionic gonadotropin; in vitro fertilization; menstrual cycleassisted reproductive technologyEndocrinology Diabetes and MetabolismObstetrics and Gynecologyhuman chorionic gonadotropinSettore MED/40 - Ginecologia E Ostetriciain vitro fertilizationProgesteronemenstrual cycleGynecological Endocrinology
researchProduct